Featured Stories
INTERVIEW WITH Martina Perharič, Medis CEO
We All Deserve the Same Treatment Options
We are pleased to announce the publication of an insightful interview with our Martina Perharič, PhD, in Magazine Lekarništvo issued by the Slovene Chamber of...
Read More
HR Team of the Year
Medis Wins HR Team of the Year 2023 Award
We are proud to announce that we have won the prestigious HR Team of the Year 2023 award!
Read More
New partnership with Pharmalink
Our Violin will be marketed in the United Arab Emirates
Medis has announced a new partnership with Pharmalink, a distinguished pharmaceutical company in the Gulf Cooperation Council region, to commercialize Medis'...
Read More
Maja Strnad Cestar has been appointed as the new CEO
Upcoming Changes in Medis Leadership
Martina Perharič, the current CEO of Medis, will transition to a new role as Chief Business Officer (CBO) of Pharmaceuticals, effective 1 August 2023. At the...
Read More
Discover the potential
Combining Forces to Reach Patients with Rare Diseases Across the Globe
World Orphan Drug Alliance (WODA) is a new global alliance of full-service regional distributors for orphan drugs.
Read More
New partnership
Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies
Medis will be an exclusive partner for the commercialization of three innovative products in 9 different markets across the CEE region.
Read More